Spain gives go ahead to research using therapeutic cloning
By Typically Spanish,
Typically Spanish
| 01. 24. 2008
The Spanish Commission for the Control of the Donation and Use of Human Stem Cells, a body which depends on the Ministry for Health and Consumer Affairs, has given the green light to the first project in Spain which will use the technique known as nucleus transfer. This is therapeutic cloning to obtain lines of stem cells which are prepared specifically from the patient.
The research is led by Miodrag Stojkovic at the Centro Prínciple Felipe de Valencia, and is intended to investigate the molecular bases of two neurological illnesses, child epilepsy and hereditary palsy. Stojkovic was the first European scientist who managed to clone a human embryo from embryonic stem cells.
The Ministry for Health has also given its support to two other studies, one in Valencia and another in Madrid, but the final approval still has to be obtained from the regional governments in each region.
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Anna Collinson, Maryam Ahmed and Bella McShane, BBC | 03.12.2024
Women who freeze their eggs are being misled by some UK clinics about their chances of having a baby, a fertility charity says.
The Fertility Network was reacting to BBC analysis that found 41% of clinics offering the service privately...
By Isabelle Bartram, Guest Contributor
| 03.13.2024
Note: This article was originally published in February 2024 in issue 268 of the German-language journal Der Gen-ethische Informationsdienst (GID). It is also part of an English-language dossier on Heritable Human Genome Editing published at the same time. Minor edits have been made.
Calls for German embryo research
Pressure on the German Embryo Protection Act is growing. The scientific community is launching a renewed attack on the controversial law and demands access to embryos for so-called high-ranking research objectives. "Germline therapies" are...
By Andrew Joseph, STAT | 02.22.2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.
But as the country marks two years this...